1. The Evaluation of Central Corneal Thickness and Intraocular Pressure in Conjunction with Tear IGF-1 Levels in Patients with Acromegaly
- Author
-
Ali Okuyucu, Elif Kilic Kan, Emrah Kan, and Ondokuz Mayıs Üniversitesi
- Subjects
Adult ,Male ,Intraocular pressure ,Disease status ,medicine.medical_specialty ,Eye Diseases ,genetic structures ,Cross-sectional study ,030209 endocrinology & metabolism ,Central corneal thickness ,Cornea ,Tonometry, Ocular ,03 medical and health sciences ,Basal (phylogenetics) ,0302 clinical medicine ,Ophthalmology ,Acromegaly ,medicine ,Humans ,In patient ,Insulin-like growth factor ,Insulin-Like Growth Factor I ,Intraocular Pressure ,business.industry ,Significant difference ,General Medicine ,Middle Aged ,medicine.disease ,eye diseases ,Tear collection ,Surgery ,Cross-Sectional Studies ,Tears ,Correlation analysis ,030221 ophthalmology & optometry ,Female ,sense organs ,business ,Biomarkers - Abstract
Purpose To compare the central corneal thickness (CCT), intraocular pressure (IOP), and tear insulin-like growth factor 1 (IGF-1) levels between patients with acromegaly and a control group and to evaluate the possible effect of tear IGF-1 and duration of the disease on CCT and IOP. Methods We included 31 patients with acromegaly (study group) and 40 age- and sex-matched controls in the study. Patients with acromegaly were divided into 2 subgroups based on disease status (active/inactive). All participants underwent complete ophthalmologic evaluation including CCT and IOP values. Basal tear samples were collected from both groups and tear IGF-1 levels were measured. The CCT, IOP, and tear IGF-1 levels were compared between groups and subgroups and the association between tear IGF-I levels and ocular parameters (CCT, IOP) and disease duration were also evaluated. Results Central corneal thickness, IOP, and tear IGF-1 levels did not show a significant difference between study and control groups. We also did not find a significant difference in terms of CCT, IOP, or tear IGF-1 levels between subgroups of patients. Correlation analysis did not show an association between the duration of disease and tear IGF-1 levels with CCT or IOP. Conclusions There was no significant difference in tear IGF-1 levels between patients with acromegaly and controls. Additionally, there was no correlation between disease duration and tear IGF-1 levels with CCT or IOP levels. This lack of association may suggest that tear IGF-1 levels might not have an effect on CCT or IOP findings in patients with acromegaly.
- Published
- 2017
- Full Text
- View/download PDF